Horizon Kinetics - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Horizon Kinetics ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$5,000
+25.0%
18,0000.0%0.00%
Q1 2016$4,000
-33.3%
18,0000.0%0.00%
Q4 2015$6,000
-80.6%
18,0000.0%0.00%
-100.0%
Q3 2015$31,000
-13.9%
18,000
+12.5%
0.00%0.0%
Q2 2015$36,000
+16.1%
16,0000.0%0.00%
Q1 2015$31,000
+6.9%
16,000
+45.5%
0.00%
Q4 2014$29,000
-12.1%
11,0000.0%0.00%
Q3 2014$33,000
-26.7%
11,0000.0%0.00%
-100.0%
Q2 2014$45,000
-4.3%
11,0000.0%0.00%0.0%
Q1 2014$47,00011,0000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
CAXTON CORP 28,639,349$123,436,00094.21%
Verity Asset Management, Inc. 103,021$456,0000.47%
NBW CAPITAL LLC 242,153$1,044,0000.27%
Old West Investment Management, LLC 69,997$301,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 196,639$848,0000.12%
SOPHROSYNE CAPITAL LLC 25,700$111,0000.10%
Cutler Capital Management, LLC 45,000$194,0000.08%
Rotella Capital Management, Inc. 11,700$50,0000.06%
STONERIDGE INVESTMENT PARTNERS LLC 66,397$286,0000.06%
Roundview Capital LLC 21,100$91,0000.04%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders